Singular Genomics Systems, Inc. (OMIC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.3811 |
| Open | 0.3600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.3600 - 0.3973 |
| 52-week range | 0.3100 - 1.1400 |
| Volume | |
| Avg. volume | 127,419 |
| Market cap | 29.119M |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.3000 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.75 |
- Thomson Reuters StreetEvents
Q1 2024 Singular Genomics Systems Inc Earnings Call
Q1 2024 Singular Genomics Systems Inc Earnings Call
- GuruFocus.com
Singular Genomics Systems Inc (OMIC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Amidst financial pressures, Singular Genomics Systems Inc (OMIC) showcases strategic advancements and robust demand for its innovative G4 X spatial sequencer.
GlobeNewswireSingular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the first quarter ended March 31, 2024. “The first quarter was productive and encouraging. We are focused on supporting our existing customers and getting the G4X spatial sequencer to market
© 2024 Yahoo. All rights reserved.